Tucson, Ariz. (March 2, 2023) – NBC’s TODAY Show will broadcast live from the Cologuard Classic by Exact Sciences on Friday, March 3rd. The early morning broadcast will include TODAY meteorologist and anchor Dylan Dreyer as well as colon cancer survivors attending the PGA TOUR Champions tournament. Throughout March, which is Colorectal Cancer Awareness Month, TODAY is highlighting inspiring stories and the importance of early colorectal cancer detection through screening.
TODAY Show Co-Anchor Craig Melvin has been a national advocate to end the disease since 2017, when his brother Lawrence Meadows was diagnosed with stage IV colorectal cancer at the age of 39. Meadows passed away at the age of 43. In honor of his brother, Melvin is active in supporting awareness campaigns, highlighting stories about young-onset colorectal cancer, and bringing to the forefront the disparities communities of color face when being treated or diagnosed.
The PGA TOUR Champions golf tournament is being contested at Omni Tucson National Resort’s Catalina Course, March 3rd – 5th. Played each March, the Cologuard Classic kicks off national Colorectal Cancer Awareness Month, raising awareness of colorectal cancer, highlighting different screening options, and honoring those affected by the disease.
Cologuard Classic by Exact Sciences tickets are on sale on the tournament’s website, www.CologuardClassic.com for Friday, Saturday and Sunday (March 3 - 5). Gates open each day at 9 a.m. With the TODAY Show broadcast ending prior to tournament gates opening, spectators will not be a part of the Show.
For more information on the Cologuard Classic, visit www.CologuardClassic.com.
About The Tucson Conquistadores
The Tucson Conquistadores, Inc. is a nonprofit organized for the purpose of supporting local youth and special needs amateur athletics primarily in Southern Arizona, with an emphasis on offering life enhancing opportunities to give back to the local community. The Conquistadores are comprised of up to 52 active business and professional members and a total membership of 223 who represent a cross-section of the Tucson community. The Conquistadores have raised more than $37.2 million for local charities since their inception in 1962, including more than $3,091,000 since the 2018 tournament, Cologuard’s first as title sponsor. Key beneficiaries of the Conquistadores' fundraising efforts include Southern Arizona youth athletic programs, First Tee-Tucson and colon cancer advocacy organizations. In addition to their involvement with professional golf, the group has also established the Tucson Conquistadores Foundation. Follow the Tucson Conquistadores online at www.tucsonconquistadores.com.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard® and Oncotype® tests, Exact Sciences is investing in its product pipeline to support patients before and throughout their cancer diagnosis and treatment. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.
The Cologuard test was approved by the FDA in August 2014, and results from Exact Sciences' prospective 90-site, point-in-time, 10,000-patient pivotal trial were published in the New England Journal of Medicine in March 2014. The Cologuard test is included in the American Cancer Society's (2018) colorectal cancer screening guidelines and the recommendations of the U.S. Preventive Services Task Force (2021) and National Comprehensive Cancer Network (2016). The Cologuard test is indicated to screen adults 45 years of age and older who are at average risk for colorectal cancer by detecting certain DNA markers and blood in the stool. Do not use the Cologuard test if you have had precancer, have inflammatory bowel disease and certain hereditary syndromes, or have a personal or family history of colorectal cancer. The Cologuard test is not a replacement for colonoscopy in high-risk patients. The Cologuard test performance in adults ages 45-49 is estimated based on a large clinical study of patients 50 and older. The Cologuard test performance in repeat testing has not been evaluated.
The Cologuard test result should be interpreted with caution. A positive test result does not confirm the presence of cancer. Patients with a positive test result should be referred for colonoscopy. A negative test result does not confirm the absence of cancer. Patients with a negative test result should discuss with their doctor when they need to be tested again. Medicare and most major insurers cover the Cologuard test. For more information about the Cologuard test, visit www.cologuard.com. Rx only.
ABOUT PGA TOUR CHAMPIONS
PGA TOUR Champions is a membership organization of professional golfers age 50 and older, including 34 members of the World Golf Hall of Fame. The Tour’s mission is to provide financial opportunities for its players, entertain and inspire its fans, deliver substantial value to its partners, create outlets for volunteers to give back and generate significant charitable and economic impact in tournament communities. Follow PGA TOUR Champions online at PGATOUR.com, on Facebook, on Twitter (@ChampionsTour), on Instagram (@pgatourchampions) and on TikTok (pgatourchampions).
All events are televised in the United States, with most receiving complete coverage on Golf Channel, the exclusive cable-television partner of PGA TOUR Champions. Tournament programming is available via 25+ TV linear partners in 145+ countries and territories, with 25 channels carrying long-form and/or highlights coverage, and 200+ hours of live coverage distributed in 135+ countries and territories. Programming is also available via the OTT platform GOLFTV powered by PGA TOUR in every market outside of the United States, excluding China and Korea, with live coverage distributed in 130+ countries and territories.